These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7260869)

  • 1. Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.
    Prosnitz LR; Lawson JP; Friedlaender GE; Farber LR; Pezzimenti JF
    Cancer; 1981 Jun; 47(12):2793-7. PubMed ID: 7260869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis in patients with malignant lymphoma: a review of twenty-five cases.
    Engel IA; Straus DJ; Lacher M; Lane J; Smith J
    Cancer; 1981 Sep; 48(5):1245-50. PubMed ID: 7272956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
    Sciascia R; Albisinni U; Ammendolia I; Barbieri E; Tondi L
    Radiol Med; 1989 Apr; 77(4):336-41. PubMed ID: 2471231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
    Hoppe RT; Portlock CS; Glatstein E; Rosenberg SA; Kaplan HS
    Cancer; 1979 Feb; 43(2):472-81. PubMed ID: 369676
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term remissions with combined modality therapy for advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR; Fischer DB
    Cancer; 1976 Jun; 37(6):2826-33. PubMed ID: 949702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 8. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
    Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
    Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
    Virgolini L; De Maglio A
    Ital J Orthop Traumatol; 1992; 18(4):543-6. PubMed ID: 1345650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of avascular necrosis of bone in patients treated for Hodgkin's disease.
    Mould JJ; Adam NM
    Clin Radiol; 1983 Mar; 34(2):231-6. PubMed ID: 6825406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
    Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
    DeVita VT
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):913-4. PubMed ID: 500419
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
    Prosnitz LR; Farber LR; Kapp DS; Bertino JR; Nordlund M; Lawrence R
    Cancer Treat Rep; 1982 Apr; 66(4):871-9. PubMed ID: 6176322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
    Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
    J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 18. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Carella AM; Congiu AM; Gaozza E; Mazza P; Ricci P; Visani G; Meloni G; Cimino G; Mangoni L; Coser P
    J Clin Oncol; 1988 Sep; 6(9):1411-6. PubMed ID: 2458439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.